Thomas Hofmarcher
- Economics and Econometrics top 5%
- Oncology
- Sociology and Political Science
- Pulmonary and Respiratory Medicine
- General Health Professions
- Co-authors
- Peter LindgrenNils WilkingBengt JönssonSixten BorgAnders HåkanssonUlla RomildErik PlugCecilia Linde
- Topics
- Economic and Financial Impacts of Cancer (11 papers)Health Systems, Economic Evaluations, Quality of Life (10 papers)Pharmaceutical Economics and Policy (5 papers)
- Partner nations
- SwedenUnited KingdomNetherlands
In The Last Decade
Thomas Hofmarcher
21 papers receiving 509 citations
Peers
Comparison fields: 5 of 114
- Economics and Econometrics 227
- Oncology 123
- Sociology and Political Science 59
- Pulmonary and Respiratory Medicine 57
- General Health Professions 53
Countries citing papers authored by Thomas Hofmarcher
This map shows the geographic impact of Thomas Hofmarcher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Hofmarcher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Hofmarcher more than expected).
Fields of papers citing papers by Thomas Hofmarcher
This network shows the impact of papers produced by Thomas Hofmarcher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Hofmarcher. The network helps show where Thomas Hofmarcher may publish in the future.
Co-authorship network of co-authors of Thomas Hofmarcher
This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Hofmarcher. A scholar is included among the top collaborators of Thomas Hofmarcher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Hofmarcher. Thomas Hofmarcher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 5 | |
| 3 | 2 | |
| 4 | 8 | |
| 5 | 9 | |
| 6 | 14 | |
| 7 | 6 | |
| 8 | 68 | |
| 9 | 8 | |
| 10 | 3 | |
| 11 | 5 | |
| 12 | 38 | |
| 13 | 201 | |
| 14 | 5 | |
| 15 | 9 | |
| 16 | Comparator Report on Patient Access to Cancer Medicines in Europe Revisited - A UK Perspective | 1 |
| 17 | 90 | |
| 18 | Comparator report on patient access to cancer medicines in Europe revisited | 18 |
| 19 | 21 | |
| 20 | ACCESS TO HIGH-QUALITY ONCOLOGY CARE ACROSS EUROPE | 3 |
About Thomas Hofmarcher
Thomas Hofmarcher is a scholar working on Economics and Econometrics, Gender Studies and Hematology, having authored 22 papers that have together received 521 indexed citations. Recurring topics across this work include Economic and Financial Impacts of Cancer (11 papers), Health Systems, Economic Evaluations, Quality of Life (10 papers) and Pharmaceutical Economics and Policy (5 papers). The work is most often cited by research in Economics and Econometrics (227 citations), Oncology (123 citations) and Hematology (30 citations). Thomas Hofmarcher has collaborated with scholars based in Sweden, United Kingdom and Netherlands. Frequent co-authors include Peter Lindgren, Nils Wilking, Bengt Jönsson, Sixten Borg, Anders Håkansson, Ulla Romild, Erik Plug, Cecilia Linde, Tomáš Doležal and Carl A. Baxter. Their work appears in journals such as The Lancet, Journal of Clinical Oncology and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.